News & Perspective

Nov 16, 2018

Nov 16, 2018

Stewardship / Resistance Scan for Nov 16, 2018

Improper prescribing in the ER
Hospital stewardship in China
Antibiotic use in Poland
Swiss AMR-related illness, deaths

Nov 17, 2017

Nov 17, 2017

ASP Scan (Weekly) for Nov 17, 2017

Primary care stewardship
No-touch superbug disinfection
Surgical antimicrobial prescribing
Ceftriaxone-resistant gonorrhea
E coli ST131
Single-room ICU design
ECDC CRE guidance
European research funding
Optimal MDR-TB treatment
Real-time resistance tracker
Salmonella in calves
Drug-resistant malaria controversy
US AMR progress
Antimicrobial use in Northern Ireland
Resistance in space

Mar 31, 2017

Mar 31, 2017

ASP Scan (Weekly) for Mar 31, 2017

Antibiotic tax credit
Antibiotic overprescribing
Drug-tainted manure affects soil
Fighting MRSA biofilms
C diff in surgical patients
Diagnostic test competition
MDR-TB in African migrants
Stewardship in Aruba

Mar 27, 2017

Mar 27, 2017

Stewardship / Resistance Scan for Mar 27, 2017

Diagnostic test competition
MDR-TB in African migrants
Stewardship in Aruba

Dec 23, 2016

Dec 23, 2016

ASP Scan (Weekly) for Dec 23, 2016

Hospital penalties for resistant bugs
Bacterial vs viral infections
Antibiotics in food animals
Fungal disease tests
MDR-TB in migrants
Bacteriophage study

Dec 21, 2016

Dec 21, 2016

Stewardship / Resistance Scan for Dec 21, 2016

Antibiotics in food animals
Fungal disease tests

Jun 09, 2011

Jun 09, 2011

Sprouts data complicate outbreak investigation

(CIDRAP News) – An epidemiologic report from German investigators yesterday said the initial case-control study found that just 28% of patients reported they had eaten sprouts, the lead suspect in Europe's Escherichia coli outbreak, pointing up a factor can be difficult to interpret in foodborne illness situations.

Sort Results By:

 Sort Results By:

Narrow results by:

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by

  Become an underwriter»